😎 Summer Sale Exclusive - Up to 50% off AI-powered stock picks by InvestingProCLAIM SALE

Medical device maker Stryker to buy Wright Medical for $4 billion

Published 11/04/2019, 07:42 AM
© Reuters.  Medical device maker Stryker to buy Wright Medical for $4 billion

(Reuters) - Medical device maker Stryker Corp (N:SYK) said on Monday it would buy smaller rival Wright Medical Group (O:WMGI) for about $4 billion in cash, to strengthen its upper-body joint implants business.

The deal for $30.75 per share of Wright represents a premium of 39.7% to the company's close on Friday.

Shares of Wright Medical rose 31% to $28.85 in premarket trading.

Including debt, the deal values Wright at about $5.4 billion and is expected to close in the second half of 2020.

Wright Medical is among the top makers of implants to treat upper-body joint injuries in areas such as the shoulder and wrist as well as lower body including the foot and ankle.

Bloomberg reported on Friday that Wright Medical was working with financial advisers and was exploring a potential sale.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.